COMMUNIQUÉ DE PRESSE publié le 24/10/2025 à 07:44, il y a 1 année Ottobock makes follow-on cornerstone investment in NeuroTech company ONWARD® Medical Ottobock strengthens investment in NeuroTech company ONWARD Medical, supporting innovative therapies for spinal cord injury. Companies deepen strategic partnership for joint innovation in NeuroTech, NeuroOrthotics, and Exoskeletons Strategic Partnership Investment Ottobock ONWARD Medical NeuroTech
COMMUNIQUÉ DE PRESSE publié le 24/10/2025 à 07:30, il y a 1 année Circus SE Secures Core Technologies Through Six New Defense Patents Circus SE secures core defense technologies with six new patents for autonomous AI robot CA-M, enhancing competitive advantage in global defense market Circus SE Global Market Patents Defense Technologies Autonomous AI Robot
COMMUNIQUÉ DE PRESSE publié le 24/10/2025 à 07:30, il y a 1 année Communiqué de presse : T3 : croissance continue du chiffre d’affaires et du bénéfice
COMMUNIQUÉ DE PRESSE publié le 24/10/2025 à 07:30, il y a 1 année Press release: Q3: continued sales and earnings progress
COMMUNIQUÉ DE PRESSE publié le 24/10/2025 à 07:05, il y a 1 année LEPAS Elegant Technology, Defined by You: LEPAS Fun Test Drive Interprets a New Paradigm for Intelligent Driving via User Co-Creation LEPAS Fun Test Drive showcases LEPAS's elegant technology through user co-creation for intelligent driving experiences. Events highlight Chery Group's innovative ecosystem vision Intelligent Driving Chery Group LEPAS Elegant Technology User Co-Creation
COMMUNIQUÉ DE PRESSE publié le 24/10/2025 à 07:00, il y a 1 année EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes interim report for the first nine months of 2025, reporting CHF 106 mn net profit. More details at report.bbbiotech.ch/Q325 Financial Results Investment Company Net Profit BB Biotech AG Interim Report
COMMUNIQUÉ DE PRESSE publié le 24/10/2025 à 07:00, il y a 1 année BB Biotech Q3 2025: Portfolio outperformance amid early signs of sector recovery BB Biotech AG reports strong Q3 2025 performance with portfolio outperforming Nasdaq Biotech Index, driven by solid net profit, key company milestones, and strategic investments BB Biotech AG Interim Report Sector Recovery Q3 2025 Portfolio Outperformance
COMMUNIQUÉ RÉGLEMENTÉ publié le 24/10/2025 à 07:00, il y a 1 année Safran publie son chiffre d’affaires du 3ème trimestre 2025 Safran publie un chiffre d'affaires en hausse de 18,3% au 3e trimestre 2025 et révise à la hausse ses perspectives annuelles, notamment pour les moteurs LEAP et les activités d'après-vente Chiffre D'affaires Safran Perspectives Annuelles Moteurs LEAP 3e Trimestre 2025
COMMUNIQUÉ RÉGLEMENTÉ publié le 24/10/2025 à 07:00, il y a 1 année Safran reports third quarter 2025 revenue Safran reports strong Q3 2025 revenue growth of 18.3% reaching €7,852 million. FY guidance raised with solid organic growth in civil engines aftermarket and record LEAP output Safran FY Guidance Q3 2025 Revenue Civil Engines Aftermarket LEAP Output
COMMUNIQUÉ DE PRESSE publié le 24/10/2025 à 06:59, il y a 1 année Relief Therapeutics Convenes Extraordinary General Meeting Relief Therapeutics announces Extraordinary General Meeting to seek shareholder approval for business combination with NeuroX Group SA EGM Business Combination Extraordinary General Meeting Relief Therapeutics NeuroX Group SA
Publié le 03/11/2026 à 11:30, il y a 3 heures 28 minutes Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital
Publié le 03/11/2026 à 07:00, il y a 7 heures 58 minutes bioMérieux – Third-Quarter 2026 Business Review
Publié le 03/11/2026 à 07:00, il y a 7 heures 58 minutes bioMérieux – Information financière du 3ème trimestre 2026
Publié le 02/11/2026 à 21:08, il y a 17 heures 50 minutes GROUPE SFPI : BILAN CONTRAT DE LIQUIDITE S1 2026
Publié le 03/11/2026 à 14:31, il y a 27 minutes First Breach Adds Inspection Equipment and Secures Strategic Supply Agreements to Support Ammunition Production
Publié le 03/11/2026 à 14:00, il y a 58 minutes Global Education Communities Corp. Provides Corporate Update on Student Housing Portfolio and Development Projects
Publié le 03/11/2026 à 13:48, il y a 1 heure 10 minutes EonX Announces Strategic Technology Partnership with Metcash, Australia's Leading Wholesaler and Service Provider to Independent Business Operators
Publié le 03/11/2026 à 13:35, il y a 1 heure 23 minutes ESGold Expands Historic Mine Waste Reclamation Strategy With Second MOU, Bringing Total Proposed Annual Aggregate Supply to 500,000 Tonnes
Publié le 03/11/2026 à 13:30, il y a 1 heure 28 minutes Nextech3D.ai to Showcase AI-Powered Event Technology at IAEE Expo Expo 2026
Publié le 03/11/2026 à 14:47, il y a 11 minutes Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
Publié le 03/11/2026 à 13:00, il y a 1 heure 58 minutes QUANTRO Therapeutics secures key Austrian research grant to build its AI-powered drug discovery platform
Publié le 03/11/2026 à 12:25, il y a 2 heures 33 minutes swissnet Group secures largest contract in company history worth approximately EUR 10 million
Publié le 03/11/2026 à 12:10, il y a 2 heures 48 minutes LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization